Global AI in Medical Imaging Market: Forecasts, Competitive Landscape, and Reimbursement-Driven Monetization, 2024A-2035E | Enterprise and Cloud Adoption Fuels Growth
Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Global AI in Medical Imaging Horizon: Forecasts, Competitive Architecture, and Reimbursement-Driven Monetization, 2024A-2035E" has been added to ResearchAndMarkets.com's offering.
The report delivers a global analysis of artificial intelligence in medical imaging from 2024A-2035E, combining market sizing, segment forecasts, reimbursement-driven monetization, competitive dynamics, regulatory developments and strategic implications. Designed for vendors, healthcare providers and investors, it examines the commercial evolution of medical imaging AI across CT, MRI, X-ray and digital radiography, mammography and DBT, ultrasound, nuclear imaging and PET.
Market value is shifting from stand-alone algorithms toward workflow integration, enterprise deployment, recurring software revenue, reimbursement maturity, cloud infrastructure and pay-per-use models. The report focuses on monetization, explaining why AI tools with comparable technical capabilities or regulatory profiles can generate significantly different commercial outcomes. Key variables include payer coverage, clinical evidence, procurement structures, workflow integration, buyer type and the ability to scale across enterprise environments.
Key Questions Addressed
Medical Imaging AI Market Outlook
The report presents a reconciled 2024A-2035E market model spanning modality, clinical area, clinical application, technology layer, revenue stream, end-user organization, geography and reimbursement tier. Base, Bull and Bear scenarios, supported by sensitivity analysis, provide a structured outlook for market development.
Base-case growth is driven by reimbursement expansion, enterprise platform adoption, AI-enabled productivity, cloud deployment and disease-specific quantitative analytics. The reimbursement framework distinguishes mature reimbursed AI, developing reimbursement categories, non-reimbursed productivity AI, and hardware-embedded or out-of-tier AI. These categories draw from different budgets and require distinct pricing, evidence and commercialization strategies.
Key Market Trends
Competitive Landscape
Competition is assessed across imaging OEMs; enterprise imaging and PACS, RIS and VNA platforms; AI-native clinical platforms; reimbursed quantitative analytics companies; breast and oncology AI vendors; reconstruction and acquisition AI providers; reporting and workflow automation companies; AI orchestration and governance platforms; cloud infrastructure providers; and provider-network AI platforms. The report also evaluates M&A and partnership implications across these control points.
Companies discussed include GE HealthCare, Siemens Healthineers, Philips, Canon Medical, Fujifilm, United Imaging, Pro Medicus, Sectra, Intelerad, Agfa HealthCare, Aidoc, Viz.ai, RapidAI, Qure.ai, Annalise.ai, DeepHealth / RadNet, HeartFlow, Cleerly, Elucid, Circle Cardiovascular Imaging, Lunit, iCAD, ScreenPoint, Hologic, Vara, Rad AI, Microsoft / Nuance, deepc, CARPL.ai, Ferrum Health, Blackford, Incepto, AWS, Microsoft Azure, Google Cloud and NVIDIA.
Report Coverage
Intended Audience
The report supports market-entry planning, product strategy, investment analysis, corporate development and go-to-market decisions. Readers can use it to compare opportunities across modalities and clinical applications, assess reimbursement exposure, identify high-potential medical imaging AI segments, benchmark competitive positioning and evaluate partnership or acquisition options through 2035E.
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/4ogq6r
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.